Twenty-one companies in the healthcare sector released their quarterly results in the week ending August 1. With this, over ...

Concerns over US economic growth have taken center stage despite a solid corporate earnings season from S&P 500 companies.

AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...

Once a market darling during the early pandemic years, Pfizer (NYSE: PFE) has been on a straight southbound path for several ...

As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports ...

The earnings season enters its second busiest week. After the shockingly weak jobs report, concerns about the economy creep ...

In terms of fundamentals, Pfizer currently boasts a market capitalization of $132 billion. Over the last twelve months, the ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.